+1-888-308-5802     
News Contact Us

Canada’s Canopy Growth acquires C3 Cannabinoid Compound Company

Author : Pankaj Singh | Published Date : 2019-05-03 
  • C3 Cannabinoid Company is one of the foremost distributor and manufacturer of dronabinol, a registered pharmaceutical medicine in Denmark, Switzerland, Austria, and Germany.
     
  • C3 would be an excellent addition to the Canopy’s European infrastructure including a robust sales and marketing setup already serving healthcare practitioners and pharmacies.

The Canada-based Canopy Growth Corporation has reportedly announced that it has successfully acquired C3 Cannabinoid Compound Company – a Bionorica SE-founded German firm. As per trusted sources, the acquisition deal would bring together the world’s foremost full-spectrum medical cannabis offerings along with single cannabinoid medicines.

Reportedly, the all cash-deal is being valued at about CDN 342.9 million. Industry experts claim that the deal would expand Canopy Growth Corporation’s reach in the European nations with prescription medicines and would allow it to access a wealth of intellectual property that the company has created over the last 2 decades via research and development into natural and synthetic cannabis medical products.

The Co-CEO and Chairman of Canopy Growth Corporation, Bruce Linton was reportedly quoted saying that the new acquisition would enable the company to offer more options to doctors across Europe and speed up the pace of commercial sales, drive forward new innovations, and increase the company’s economic footprint on the continent.

The goal of Canopy Growth Corporation is to build upon the extraordinary reputation of C3 and decades of success as the company moves to a unique range of medical cannabis therapies which would allow physicians globally to treat their patients in a better manner, Linton further added.

Reportedly, the chief medicinal offering of C3 is dronabinol – a pure chemical compound with uniform concentrations of tetrahydrocannabinol (THC). It is available in Germany, Denmark, and Austria for nausea and vomiting refractory to traditional treatment in cancer pain, oncology and palliative care. For the record, THC is one of the active ingredients found in cannabis plants and is responsible for various pharmacological effects.

 

Source Credit:  https://finance.yahoo.com/news/canopy-growth-acquires-germanys-c3-110000225.html

https://www.cannabisbusinesstimes.com/article/canopy-growth-acquires-c3-cannabinoid-compound-company/

About Author

Pankaj Singh

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

Revival in UK hotel bookings after COVID-19 downturn, says Premier Inn

Published Date: 2020-07-09         Author: Pankaj Singh

UK has registered a revival in hotel bookings for conventional regional tourist destinations as people have started planning summer trips to the seaside and countryside, stated Premier Inn owner. The Chief Executive of Whitbread, Alison Brittain, has stated that larger cities like London continue... Read More

Fujitsu gravitates toward 'new normal' with new office working style

Published Date: 2020-07-08         Author: Pankaj Singh

Fujitsu Limited, a Japanese multinational IT company headquartered in Tokyo, has reportedly announced that it will boost its shift to becoming a digital transformation organization with an ambitious plan to transform the working style for its employees in Japan in the light of COVID-19 pandemic. ... Read More

Britain nears USD 625 million COVID-19 vaccine deals with Sanofi/GSK

Published Date: 2020-07-06         Author: Pankaj Singh

With over 100 vaccines are being tested and developed to stop the spread of COVID-19, it seems that governments worldwide are racing to secure supplies of vaccines even before their efficiency is proven. As per the latest news, Britain government is close to a USD 625 million supply deals with Sanof... Read More

© 2020 Fractovia. All Rights Reserved